[Requirements for drug approval and additional benefits assessment: Regulatory aspects and experiences]. [electronic resource]
Producer: 20170106Description: 376-85 p. digitalISSN:- 1433-0407
- Cost-Benefit Analysis -- legislation & jurisprudence
- Drug Approval -- economics
- Drug Industry -- legislation & jurisprudence
- Endpoint Determination -- methods
- Germany
- Government Regulation
- Health Care Reform -- economics
- Legislation, Drug
- Marketing of Health Services -- economics
- Outcome Assessment, Health Care -- economics
- Quality Assurance, Health Care -- economics
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.